EPP

Clinical trials for EPP explained in plain language.

Never miss a new study

Get alerted when new EPP trials appear

Sign up with your email to follow new studies for EPP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New oral drug shows promise for rare sun allergy conditions

Disease control Recruiting now

This study is for people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain and skin reactions to sunlight. The purpose is to check the long-term safety of an oral medication called dersimelagon. About 301 participant…

Matched conditions: EPP

Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

EPP

Get alerted when new EPP trials appear

New oral drug shows promise for rare sun allergy conditions